Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantationTakuya Sekine, Katayoun Rezvani, Catherine Sobieski et al.|Blood|2016Cited by 62
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agentsNicholas J. Short, Hagop M. Kantarjian, Muharrem Müftüoğlu et al.|Journal of Hematology & Oncology|2023Cited by 52
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z. Carter, Michael Andreeff, Po Yee Mak et al.|Blood Cancer Journal|2023Cited by 33